A Prospective, Multi-Center Trial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2013
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 21 Feb 2011 Additional lead trial investigator (William Read) identified as reported by Moores UCSD Cancer Center.
- 21 Feb 2011 New source identified and integrated (Moores UCSD Cancer Center; 6839).
- 01 Apr 2010 New trial record